Current State of Alzheimer's Disease Research and Therapeutics
This new volume of
Audience
Pharmacologists, immunologists, and biochemists
Hardbound, 400 Pages
Published: August 2012
Imprint: Academic Press
ISBN: 978-0-12-394816-8
Contents
- Hsp90 Modulation for the Treatment of Alzheimers Disease
- Using Pittsburgh Compound B for In-vivo PET Imaging of Fibrillar Amyloid-beta
- Mitochondrial Abnormalities in Alzheimer's Disease: Possible Targets for Therapeutic Intervention
- g-Secretase as a Target for Alzheimers Disease
- Altering Mitochondrial Dysfunction as an Approach to Treating Alzheimers Disease
- scyllo-Inositol, Preclinical and Clinical Data for Alzheimers disease
- Beyond Amyloid: The Future of Therapeutics for Alzheimers Disease
- Activation of Protein Kinase C Isozymes for the Treatment of Dementias
- STriatal Enriched Protein Tyrosine Phosphatase in Alzheimers Disease
- Estrogen Regulation of Mitochondrial Bioenergetics: Implications for Prevention of Alzheimers Disease
Huiping Zhao, Mary L. Michaelis and Brian S. J. Blagg Ann D. Cohen, Gil D. Rabinovici, Chester A. Mathis, William J. Jagust, William E. Klunk and Milos D. Ikonomovic Diana F. Silva, J. Eva Selfridge, Jianghua Lu, Lezi E, Sandra M. Cardoso, and Russell H. Swerdlow Michael S. Wolfe Jerry R. Colca and Douglas L. Feinstein Keran Ma, Lynsie A.M. Thomason and JoAnne McLaurin Rachel F Lane, Diana W Shineman, John W Steele, Linda (Bobbi) H Lee and Howard M Fillit Miao-Kun Sun and Daniel L. Alkon Jian Xu, Pradeep Kurup, Angus C. Nairn and Paul J. Lombroso Jia Yao and Roberta Diaz Brinton

